Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix vs Goserelin in Chinese Prostate Cancer Patients
NCT01744366Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jan 2013
- Primary completion
- May 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Jan 2013; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01744366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01744366.